Global Tumor Fluid Biopsy Industry Growth and Trends Forecast to 2031
Description
Summary
According to APO Research, The global Tumor Fluid Biopsy market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Tumor Fluid Biopsy include Cellmax Life, Exact Science, Amoy Diagnostics Co, Berry Genomics Co, Genetronhealth, GenoploRare, HaploX Biotechnology Co, New Horizon Health Limited and Burning Rock Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Fluid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Fluid Biopsy.
The Tumor Fluid Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Fluid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Tumor Fluid Biopsy Segment by Company
Cellmax Life
Exact Science
Amoy Diagnostics Co
Berry Genomics Co
Genetronhealth
GenoploRare
HaploX Biotechnology Co
New Horizon Health Limited
Burning Rock Biotech
Guangzhou Wondfo Biotech
YZY Biopharma
Tumor Fluid Biopsy Segment by Type
CTDNA Detection
CTC Detection
Other
Tumor Fluid Biopsy Segment by Application
Hospital
Third Party Organization
Other
Tumor Fluid Biopsy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Fluid Biopsy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Fluid Biopsy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Fluid Biopsy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor Fluid Biopsy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
According to APO Research, The global Tumor Fluid Biopsy market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.
North American market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Asia-Pacific market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
Europe market for Tumor Fluid Biopsy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.
The major global companies of Tumor Fluid Biopsy include Cellmax Life, Exact Science, Amoy Diagnostics Co, Berry Genomics Co, Genetronhealth, GenoploRare, HaploX Biotechnology Co, New Horizon Health Limited and Burning Rock Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Fluid Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Fluid Biopsy.
The Tumor Fluid Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Fluid Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Tumor Fluid Biopsy Segment by Company
Cellmax Life
Exact Science
Amoy Diagnostics Co
Berry Genomics Co
Genetronhealth
GenoploRare
HaploX Biotechnology Co
New Horizon Health Limited
Burning Rock Biotech
Guangzhou Wondfo Biotech
YZY Biopharma
Tumor Fluid Biopsy Segment by Type
CTDNA Detection
CTC Detection
Other
Tumor Fluid Biopsy Segment by Application
Hospital
Third Party Organization
Other
Tumor Fluid Biopsy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Fluid Biopsy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Fluid Biopsy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Fluid Biopsy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor Fluid Biopsy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Table of Contents
102 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tumor Fluid Biopsy Market Size Overview by Region 2020 VS 2024 VS 2031
- 1.4 Global Tumor Fluid Biopsy Market Size by Region (2020-2031)
- 1.4.1 Global Tumor Fluid Biopsy Market Size by Region (2020-2025)
- 1.4.2 Global Tumor Fluid Biopsy Market Size by Region (2026-2031)
- 1.5 Key Regions Tumor Fluid Biopsy Market Size (2020-2031)
- 1.5.1 North America Tumor Fluid Biopsy Market Size Growth Rate (2020-2031)
- 1.5.2 Europe Tumor Fluid Biopsy Market Size Growth Rate (2020-2031)
- 1.5.3 Asia-Pacific Tumor Fluid Biopsy Market Size Growth Rate (2020-2031)
- 1.5.4 South America Tumor Fluid Biopsy Market Size Growth Rate (2020-2031)
- 1.5.5 Middle East & Africa Tumor Fluid Biopsy Market Size Growth Rate (2020-2031)
- 2 Tumor Fluid Biopsy Market by Type
- 2.1 Type Introduction
- 2.1.1 CTDNA Detection
- 2.1.2 CTC Detection
- 2.1.3 Other
- 2.2 Global Tumor Fluid Biopsy Market Size by Type
- 2.2.1 Global Tumor Fluid Biopsy Market Size Overview by Type (2020-2031)
- 2.2.2 Global Tumor Fluid Biopsy Historic Market Size Review by Type (2020-2025)
- 2.2.3 Global Tumor Fluid Biopsy Market Size Forecasted by Type (2026-2031)
- 2.3 Global Tumor Fluid Biopsy Market Size by Regions
- 2.3.1 North America Tumor Fluid Biopsy Market Size Breakdown by Type (2020-2025)
- 2.3.2 Europe Tumor Fluid Biopsy Market Size Breakdown by Type (2020-2025)
- 2.3.3 Asia-Pacific Tumor Fluid Biopsy Market Size Breakdown by Type (2020-2025)
- 2.3.4 South America Tumor Fluid Biopsy Market Size Breakdown by Type (2020-2025)
- 2.3.5 Middle East and Africa Tumor Fluid Biopsy Market Size Breakdown by Type (2020-2025)
- 3 Tumor Fluid Biopsy Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Third Party Organization
- 3.1.3 Other
- 3.2 Global Tumor Fluid Biopsy Market Size by Application
- 3.2.1 Global Tumor Fluid Biopsy Market Size Overview by Application (2020-2031)
- 3.2.2 Global Tumor Fluid Biopsy Historic Market Size Review by Application (2020-2025)
- 3.2.3 Global Tumor Fluid Biopsy Market Size Forecasted by Application (2026-2031)
- 3.3 Global Tumor Fluid Biopsy Market Size by Regions
- 3.3.1 North America Tumor Fluid Biopsy Market Size Breakdown by Application (2020-2025)
- 3.3.2 Europe Tumor Fluid Biopsy Market Size Breakdown by Application (2020-2025)
- 3.3.3 Asia-Pacific Tumor Fluid Biopsy Market Size Breakdown by Application (2020-2025)
- 3.3.4 South America Tumor Fluid Biopsy Market Size Breakdown by Application (2020-2025)
- 3.3.5 Middle East and Africa Tumor Fluid Biopsy Market Size Breakdown by Application (2020-2025)
- 4 Global Market Dynamics
- 4.1 Tumor Fluid Biopsy Industry Trends
- 4.2 Tumor Fluid Biopsy Industry Drivers
- 4.3 Tumor Fluid Biopsy Industry Opportunities and Challenges
- 4.4 Tumor Fluid Biopsy Industry Restraints
- 5 Competitive Insights by Company
- 5.1 Global Top Players by Tumor Fluid Biopsy Revenue (2020-2025)
- 5.2 Global Tumor Fluid Biopsy Industry Company Ranking, 2023 VS 2024 VS 2025
- 5.3 Global Tumor Fluid Biopsy Key Company Headquarters & Area Served
- 5.4 Global Tumor Fluid Biopsy Company, Product Type & Application
- 5.5 Global Tumor Fluid Biopsy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tumor Fluid Biopsy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tumor Fluid Biopsy Players Market Share by Revenue in 2024
- 5.6.3 2024 Tumor Fluid Biopsy Tier 1, Tier 2, and Tier 3
- 6 Company Profiles
- 6.1 Cellmax Life
- 6.1.1 Cellmax Life Comapny Information
- 6.1.2 Cellmax Life Business Overview
- 6.1.3 Cellmax Life Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.1.4 Cellmax Life Tumor Fluid Biopsy Product Portfolio
- 6.1.5 Cellmax Life Recent Developments
- 6.2 Exact Science
- 6.2.1 Exact Science Comapny Information
- 6.2.2 Exact Science Business Overview
- 6.2.3 Exact Science Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.2.4 Exact Science Tumor Fluid Biopsy Product Portfolio
- 6.2.5 Exact Science Recent Developments
- 6.3 Amoy Diagnostics Co
- 6.3.1 Amoy Diagnostics Co Comapny Information
- 6.3.2 Amoy Diagnostics Co Business Overview
- 6.3.3 Amoy Diagnostics Co Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.3.4 Amoy Diagnostics Co Tumor Fluid Biopsy Product Portfolio
- 6.3.5 Amoy Diagnostics Co Recent Developments
- 6.4 Berry Genomics Co
- 6.4.1 Berry Genomics Co Comapny Information
- 6.4.2 Berry Genomics Co Business Overview
- 6.4.3 Berry Genomics Co Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.4.4 Berry Genomics Co Tumor Fluid Biopsy Product Portfolio
- 6.4.5 Berry Genomics Co Recent Developments
- 6.5 Genetronhealth
- 6.5.1 Genetronhealth Comapny Information
- 6.5.2 Genetronhealth Business Overview
- 6.5.3 Genetronhealth Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.5.4 Genetronhealth Tumor Fluid Biopsy Product Portfolio
- 6.5.5 Genetronhealth Recent Developments
- 6.6 GenoploRare
- 6.6.1 GenoploRare Comapny Information
- 6.6.2 GenoploRare Business Overview
- 6.6.3 GenoploRare Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.6.4 GenoploRare Tumor Fluid Biopsy Product Portfolio
- 6.6.5 GenoploRare Recent Developments
- 6.7 HaploX Biotechnology Co
- 6.7.1 HaploX Biotechnology Co Comapny Information
- 6.7.2 HaploX Biotechnology Co Business Overview
- 6.7.3 HaploX Biotechnology Co Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.7.4 HaploX Biotechnology Co Tumor Fluid Biopsy Product Portfolio
- 6.7.5 HaploX Biotechnology Co Recent Developments
- 6.8 New Horizon Health Limited
- 6.8.1 New Horizon Health Limited Comapny Information
- 6.8.2 New Horizon Health Limited Business Overview
- 6.8.3 New Horizon Health Limited Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.8.4 New Horizon Health Limited Tumor Fluid Biopsy Product Portfolio
- 6.8.5 New Horizon Health Limited Recent Developments
- 6.9 Burning Rock Biotech
- 6.9.1 Burning Rock Biotech Comapny Information
- 6.9.2 Burning Rock Biotech Business Overview
- 6.9.3 Burning Rock Biotech Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.9.4 Burning Rock Biotech Tumor Fluid Biopsy Product Portfolio
- 6.9.5 Burning Rock Biotech Recent Developments
- 6.10 Guangzhou Wondfo Biotech
- 6.10.1 Guangzhou Wondfo Biotech Comapny Information
- 6.10.2 Guangzhou Wondfo Biotech Business Overview
- 6.10.3 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.10.4 Guangzhou Wondfo Biotech Tumor Fluid Biopsy Product Portfolio
- 6.10.5 Guangzhou Wondfo Biotech Recent Developments
- 6.11 YZY Biopharma
- 6.11.1 YZY Biopharma Comapny Information
- 6.11.2 YZY Biopharma Business Overview
- 6.11.3 YZY Biopharma Tumor Fluid Biopsy Revenue, Global Share and Gross Margin (2020-2025)
- 6.11.4 YZY Biopharma Tumor Fluid Biopsy Product Portfolio
- 6.11.5 YZY Biopharma Recent Developments
- 7 North America
- 7.1 North America Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 7.2 North America Tumor Fluid Biopsy Market Size by Country (2020-2025)
- 7.3 North America Tumor Fluid Biopsy Market Size Forecast by Country (2026-2031)
- 8 Europe
- 8.1 Europe Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 8.2 Europe Tumor Fluid Biopsy Market Size by Country (2020-2025)
- 8.3 Europe Tumor Fluid Biopsy Market Size Forecast by Country (2026-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 9.2 Asia-Pacific Tumor Fluid Biopsy Market Size by Country (2020-2025)
- 9.3 Asia-Pacific Tumor Fluid Biopsy Market Size Forecast by Country (2026-2031)
- 10 South America
- 10.1 South America Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 10.2 South America Tumor Fluid Biopsy Market Size by Country (2020-2025)
- 10.3 South America Tumor Fluid Biopsy Market Size Forecast by Country (2026-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Tumor Fluid Biopsy Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
- 11.2 Middle East & Africa Tumor Fluid Biopsy Market Size by Country (2020-2025)
- 11.3 Middle East & Africa Tumor Fluid Biopsy Market Size Forecast by Country (2026-2031)
- 12 Concluding Insights
- 13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
